805
Participants
Start Date
August 15, 2024
Primary Completion Date
July 30, 2025
Study Completion Date
July 30, 2025
No drug
This is a non-interventional study and no study drug will be provided.
Beijing Cancer Hospital, Beijing
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Zhejiang Provincial People's Hospital, Hangzhou
Harbin Medical University Cancer Hospital, Harbin
Affiliated Cancer Hospital of Shandong First Medical University, Jinan
Liaoning Cancer Hospital & Institute, Shenyang
The First Hospital of China Medical University, Shenyang
The First Affiliated Hospital of Soochow University, Suzhou
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan
Lead Sponsor
Daiichi Sankyo
INDUSTRY